RE: Keep going Rippers16 Jan 2022 21:32
Yes. Pointing out the potential of AVA6000, PreCision, the LG deal, shorts closing, Daewoong partnership and Point partnership, AS saying initial data on AVA6000 is very promising indeed, the timeline being about now for initial data, Avacta stating funding in place til 2023. I’m here to cause disruption…. Disruption of the bashers plan to spread negativity. Pointing out the bashers lies like no funding and TT failure or AVCT to never be profitable. Very disruptive indeed.
AVA6000 1.5bn target market. Pa.
AVA6000 56.5b target market. Pa.
Therapeutic as a whole targeting 300bn plus target market. Pa.
Daewoong deal hundreds of millions
LG deal hundreds of millions.
POINT deal 8m per drug plus profit share.
So disruptive.
Wyn is truly here just to cause disruption since he ISNT INVESTED IN AVACTA.